4.7 Review

Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial

Lorenz Leitner et al.

Summary: This study aimed to determine the effectiveness of intravesical bacteriophage therapy in treating UTIs. Findings showed that bacteriophage therapy was non-inferior to standard antibiotic treatment, but not superior to placebo bladder irrigation in terms of efficacy or safety. The safety profile of bacteriophages appears to be favorable, suggesting potential for further large-scale clinical studies on their role in UTI treatment.

LANCET INFECTIOUS DISEASES (2021)

Review Infectious Diseases

CRISPR-based strategies in infectious disease diagnosis and therapy

Alexandra Binnie et al.

Summary: CRISPR gene-editing technology has the potential to revolutionize the diagnosis and treatment of infectious diseases, offering novel approaches such as rapid diagnostic systems, drug-resistance gene identification, and targeted therapies against resistant bacteria and emerging viruses like SARS-CoV-2. Despite risks like off-target modifications, strategies are being developed to control these risks, with ongoing phase 1 clinical trials for CRISPR-based therapies for cancer and monogenic diseases.

INFECTION (2021)

Review Biochemical Research Methods

Delivery of CRISPR-Cas systems using phage-based vectors

Clement Fage et al.

Summary: Antimicrobial resistance is a global issue, and repurposing CRISPR-Cas as a therapeutic strategy against bacterial infections requires efficient delivery vectors, with engineered phages showing great potential as carriers. Recent progress in phage engineering aims to improve the efficiency of CRISPR-Cas delivery.

CURRENT OPINION IN BIOTECHNOLOGY (2021)

Review Microbiology

Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants

Kira S. Makarova et al.

NATURE REVIEWS MICROBIOLOGY (2020)

Review Infectious Diseases

How CRISPR-Cas System Could Be Used to Combat Antimicrobial Resistance

Pourya Gholizadeh et al.

INFECTION AND DRUG RESISTANCE (2020)

Article Social Sciences, Interdisciplinary

Phage therapy as a potential solution in the fight against AMR: obstacles and possible futures

Charlotte Brives et al.

PALGRAVE COMMUNICATIONS (2020)

Review Cell Biology

CRISPR/Cas9 technology as a potent molecular tool for gene therapy

Ansar Karimian et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Article Biochemistry & Molecular Biology

Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus

Rebekah M. Dedrick et al.

NATURE MEDICINE (2019)

Review Biology

Origins and evolution of CRISPR-Cas systems

Eugene Koonin et al.

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2019)

Article Biotechnology & Applied Microbiology

Encapsulation of E. coli phage ZCEC5 in chitosan-alginate beads as a delivery system in phage therapy

Abdallah S. Abdelsattar et al.

AMB EXPRESS (2019)

Article Microbiology

Conjugative Delivery of CRISPR-Cas9 for the Selective Depletion of Antibiotic-Resistant Enterococci

Marinelle Rodrigues et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

Review Medicine, Research & Experimental

CRISPR-Cas9 system: A new-fangled dawn in gene editing

Darshana Gupta et al.

LIFE SCIENCES (2019)

Review Microbiology

Phage Therapy in the Postantibiotic Era

Fernando L. Gordillo Altamirano et al.

CLINICAL MICROBIOLOGY REVIEWS (2019)

Review Biotechnology & Applied Microbiology

Bacteriophage-host arm race: an update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy

Aa Haeruman Azam et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2019)

Review Biochemistry & Molecular Biology

Type II-C CRISPR-Cas9 Biology, Mechanism, and Application

Aamir Mir et al.

ACS CHEMICAL BIOLOGY (2018)

Review Chemistry, Multidisciplinary

Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications

Chang Liu et al.

JOURNAL OF CONTROLLED RELEASE (2017)

Article Biochemistry & Molecular Biology

Extending the Host Range of Bacteriophage Particles for DNA Transduction

Ido Yosef et al.

MOLECULAR CELL (2017)

Review Engineering, Biomedical

Advancing the design and delivery of CRISPR antimicrobials

Jennie R. Fagen et al.

CURRENT OPINION IN BIOMEDICAL ENGINEERING (2017)

Review Microbiology

Next-generation precision antimicrobials: towards personalized treatment of infectious diseases

Cesar de la Fuente-Nunez et al.

CURRENT OPINION IN MICROBIOLOGY (2017)

Review Biochemistry & Molecular Biology

Evolutionary Rationale for Phases as Complements of Antibiotics

Clara Torres-Barcelo et al.

TRENDS IN MICROBIOLOGY (2016)

Review Microbiology

Bacteriophage-mediated spread of bacterial virulence genes

Jose R. Penades et al.

CURRENT OPINION IN MICROBIOLOGY (2015)

Article Multidisciplinary Sciences

Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria

Ido Yosef et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Cell & Tissue Engineering

Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells using CRISPR/Cas9

Pankaj K. Mandal et al.

CELL STEM CELL (2014)

Article Biotechnology & Applied Microbiology

Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases

Robert J. Citorik et al.

NATURE BIOTECHNOLOGY (2014)

Article Biotechnology & Applied Microbiology

Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials

David Bikard et al.

NATURE BIOTECHNOLOGY (2014)

Article Biotechnology & Applied Microbiology

Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype

Hao Yin et al.

NATURE BIOTECHNOLOGY (2014)

Article Biochemical Research Methods

Genome engineering using the CRISPR-Cas9 system

F. Ann Ran et al.

NATURE PROTOCOLS (2013)

Review Microbiology

Evolution and classification of the CRISPR-Cas systems

Kira S. Makarova et al.

NATURE REVIEWS MICROBIOLOGY (2011)

Article Biotechnology & Applied Microbiology

PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response

Kwang-Pyo Kim et al.

MICROBIAL BIOTECHNOLOGY (2008)

Article Multidisciplinary Sciences

Dispersing biofilms with engineered enzymatic bacteriophage

Timothy K. Lu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Biochemistry & Molecular Biology

Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements

FJM Mojica et al.

JOURNAL OF MOLECULAR EVOLUTION (2005)